Fresh Tracks Therapeutics, Inc. (FRTX)

Fresh Tracks Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	10.87	8.68	26.88	30.12	7.23
Short-Term Investments	0	0	0	0	4.5
Cash & Cash Equivalents	10.87	8.68	26.88	30.12	7.23
Cash Growth	25.21%	-67.71%	-10.73%	316.41%	-84.96%
Receivables	0.05	0.5	0.13	0	0
Inventory	0.55	-0.5	-0.13	0	0
Other Current Assets	0.09	1.4	2.72	3.42	6.24
Total Current Assets	11.55	10.08	29.6	33.53	17.97
Property, Plant & Equipment	0.03	0.12	0.12	0.1	0.18
Intangible Assets	0	1.47	0	0	0
Other Long-Term Assets	0	-1.41	0	0	0
Total Long-Term Assets	0.03	0.19	0.12	0.1	0.18
Total Assets	11.59	10.27	29.72	33.63	18.14
Accounts Payable	0.41	0.57	1.61	0.57	2.25
Deferred Revenue	0	0	0	0	1.8
Current Debt	0	0.05	0.07	0.37	0.08
Other Current Liabilities	1.25	2.46	3.14	5.42	6.38
Total Current Liabilities	1.66	3.08	4.81	6.35	10.5
Long-Term Debt	0	0	0	0.15	0.07
Other Long-Term Liabilities	0	0.62	0	0	0
Total Long-Term Liabilities	0	0.62	0	0.15	0.07
Total Liabilities	1.66	3.08	4.81	6.5	10.57
Total Debt	0	0.05	0.07	0.51	0.15
Debt Growth	-	-28.99%	-86.50%	238.41%	-96.74%
Common Stock	0.06	0.03	1.19	0.54	0.09
Retained Earnings	-172.16	-166.47	-145.37	-105.89	-84.98
Comprehensive Income	0	0	0	0	-0.03
Shareholders' Equity	9.93	7.19	24.91	27.14	7.57
Total Liabilities and Equity	11.59	10.27	29.72	33.63	18.14
Net Cash / Debt	10.87	8.63	26.82	29.6	11.58
Net Cash / Debt Growth	25.92%	-67.81%	-9.42%	155.69%	-70.78%
Net Cash Per Share	1.84	3.07	15.02	54.34	172.35
Working Capital	9.9	7.01	24.79	27.18	7.47
Book Value Per Share	1.68	2.56	13.96	49.81	112.75

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.